Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: Q4Q7M3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.596 |
CLV_PCSK_KEX2_1 | 135 | 137 | PF00082 | 0.596 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.532 |
DOC_CYCLIN_yCln2_LP_2 | 160 | 166 | PF00134 | 0.700 |
DOC_CYCLIN_yCln2_LP_2 | 232 | 238 | PF00134 | 0.795 |
DOC_PP2B_LxvP_1 | 222 | 225 | PF13499 | 0.819 |
DOC_PP2B_LxvP_1 | 232 | 235 | PF13499 | 0.714 |
DOC_USP7_MATH_1 | 225 | 229 | PF00917 | 0.789 |
DOC_USP7_MATH_1 | 40 | 44 | PF00917 | 0.729 |
DOC_USP7_MATH_1 | 71 | 75 | PF00917 | 0.524 |
DOC_USP7_MATH_1 | 9 | 13 | PF00917 | 0.515 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.782 |
LIG_14-3-3_CanoR_1 | 105 | 109 | PF00244 | 0.725 |
LIG_14-3-3_CanoR_1 | 136 | 146 | PF00244 | 0.794 |
LIG_BRCT_BRCA1_1 | 56 | 60 | PF00533 | 0.524 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.704 |
LIG_FHA_1 | 224 | 230 | PF00498 | 0.824 |
LIG_FHA_1 | 243 | 249 | PF00498 | 0.600 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.777 |
LIG_LIR_Apic_2 | 216 | 221 | PF02991 | 0.819 |
LIG_LIR_Nem_3 | 107 | 112 | PF02991 | 0.685 |
LIG_LIR_Nem_3 | 13 | 19 | PF02991 | 0.524 |
LIG_LIR_Nem_3 | 187 | 192 | PF02991 | 0.832 |
LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.524 |
LIG_PDZ_Class_2 | 244 | 249 | PF00595 | 0.822 |
LIG_Pex14_1 | 96 | 100 | PF04695 | 0.524 |
LIG_Pex14_2 | 47 | 51 | PF04695 | 0.524 |
LIG_REV1ctd_RIR_1 | 99 | 109 | PF16727 | 0.484 |
LIG_SH2_CRK | 16 | 20 | PF00017 | 0.524 |
LIG_SH2_CRK | 218 | 222 | PF00017 | 0.822 |
LIG_SH2_NCK_1 | 139 | 143 | PF00017 | 0.792 |
LIG_SH2_STAT3 | 236 | 239 | PF00017 | 0.794 |
LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.661 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.676 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.791 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.803 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.794 |
LIG_SUMO_SIM_anti_2 | 74 | 80 | PF11976 | 0.289 |
LIG_SUMO_SIM_par_1 | 220 | 226 | PF11976 | 0.819 |
LIG_UBA3_1 | 25 | 34 | PF00899 | 0.681 |
MOD_CK1_1 | 213 | 219 | PF00069 | 0.696 |
MOD_CK1_1 | 242 | 248 | PF00069 | 0.711 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.474 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.501 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.559 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.524 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.368 |
MOD_NEK2_2 | 45 | 50 | PF00069 | 0.375 |
MOD_PIKK_1 | 184 | 190 | PF00454 | 0.824 |
MOD_PKA_2 | 104 | 110 | PF00069 | 0.723 |
MOD_Plk_1 | 239 | 245 | PF00069 | 0.818 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.743 |
MOD_Plk_4 | 213 | 219 | PF00069 | 0.809 |
MOD_Plk_4 | 54 | 60 | PF00069 | 0.524 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.782 |
TRG_DiLeu_BaEn_1 | 75 | 80 | PF01217 | 0.432 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.524 |
TRG_ER_diArg_1 | 135 | 137 | PF00400 | 0.796 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7X345 | Leishmania donovani | 90% | 100% |
A4I5B3 | Leishmania infantum | 89% | 100% |
E9B0K9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |